Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study - Wikidata - awgldk - TriplyDB

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

http://www.wikidata.org/entity/Q29617267

about

Clinical applications of mesenchymal stem cells Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell Mesenchymal stromal cells (MSC) for treating immune-mediated inflammation post-transplantation and in autoimmunity Targeting improves MSC treatment of inflammatory bowel disease Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing Mesenchymal Stem Cells after Polytrauma: Actor and Target Strategies to Optimize Adult Stem Cell Therapy for Tissue Regeneration The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation Interaction between Mesenchymal Stem Cells and B-Cells Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine Decellularized and Engineered Tendons as Biological Substitutes: A Critical Review Mesenchymal stem cells and immunomodulation: current status and future prospects The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers Strategies to improve the immunosuppressive properties of human mesenchymal stem cells Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke Immunomodulation by mesenchymal stem cells in veterinary species Secondary treatment of acute graft-versus-host disease: a critical review Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy Stromal cell-based immunotherapy in transplantation Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment Immunomodulatory effects of adipose-derived stem cells: fact or fiction?Mesenchymal stem cells as vectors for lung cancer therapy SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Stem cell treatment of degenerative eye disease A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods Mesenchymal stem cell transplantation in multiple sclerosis Mesenchymal stem cells migration homing and tracking Mesenchymal stem cells: immune evasive, not immune privileged Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications Immunobiology of mesenchymal stem cells Immunotherapeutic potential of extracellular vesicles One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications

P2860

Q21198864-6B4D5FDA-A6ED-4429-8064-AB2CB86BD874 Q21284513-23A30CB9-29E1-436B-A2F9-E89E2C85F1F9 Q22305707-2FC23672-E49B-473E-9DCA-EC281B1807CB Q24198154-F36B3BD9-55D3-4DDD-BF12-C2397C920C11 Q24601626-AED65978-D946-4480-ABDE-2AE5F4F0DFFD Q24632520-4CFC38BD-6265-4E45-9976-ACE7DA7D340C Q26747314-AEDC6F4B-A20F-48BC-B3FE-47E4CBA29895 Q26747501-B1EB70C2-D35E-48BB-8ED0-577FB307B2DA Q26748595-3B466834-3928-47C9-B46C-621A705A0C81 Q26750859-3EC817CE-ABB3-4249-9073-B927278A0749 Q26751022-4F46A089-DBB4-4B8D-AC21-8B1744C6119F Q26751506-21F45275-0B22-4284-8BD1-D91E06EEE3E0 Q26765863-C780F105-F7BF-4118-B4B1-64E51CF1AC78 Q26770191-60152D87-D054-4C6C-91A3-C24B3AB19EA3 Q26773017-2A726140-7941-4C5D-BC99-BBD2C7320FF0 Q26777111-0951D3E9-4BAA-46CA-9C14-4FEF73373371 Q26786626-96E52D53-0312-4DC0-9562-1C7656716691 Q26796475-DDC0C427-4FDC-492D-99D1-CA98A2EFACC0 Q26800098-2E7DF5F9-2836-45B5-9D67-E4E60F56F299 Q26800181-AEA20313-723E-4F5C-83E0-C846F8B01ED5 Q26822818-04D3DC3C-D76F-4946-B90A-5C65C6F02F88 Q26823275-24A60EB6-9DC7-45BF-92CC-D12B0828CE18 Q26825272-E4BFA798-3804-4CF7-B52F-5D6BC57F1DF7 Q26851908-8033E69A-2A72-4272-832B-AEA5FD3BFA86 Q26852467-6E923CF6-9C80-45D2-8794-7C183E2C5C3A Q26853374-53938434-084B-4A5E-84D9-C478E03B2EBB Q26853443-2BC569EA-1A8B-454E-A15E-0377FBDCDCDC Q26853498-F7D5579D-3F36-4D0C-8F6F-8DC8DA2DD918 Q26853573-38B64490-4BB8-40AF-8734-C1CA0F9B6EB2 Q26865070-74FF5D99-FC48-4A1E-A6BB-CDEAC9B40051 Q26865154-D7DE4782-9E66-4264-A957-AF27A0B7D3F0 Q26998969-80B2D6AB-1B06-4E39-B3FC-A9C214BE053C Q26999783-0B6FC548-5D7B-4885-A12F-CFDE18C4CFB8 Q27003059-9FF67562-8B4C-467B-8758-BECDEA54E7B8 Q27003371-3371FA0E-08FB-49D8-B828-A3578F895489 Q27004008-27726C57-B46B-4920-A560-A7C21A6ABB36 Q27004487-E64CB3AC-2EFB-4BE9-B6B1-46DA1F706574 Q27023323-A5D11C80-62B8-4F6E-8E68-2F6FA7A5E78F Q27026711-CC73D640-18D0-4B9B-86E2-20A255B463C7 Q27026892-7E3091D4-CE38-4184-87DD-655A72FBD2ED

P2860

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

http://www.wikidata.org/entity/Q29617267

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Mesenchymal stem cells for tre ...... host disease: a phase II study

@ast

Mesenchymal stem cells for tre ...... host disease: a phase II study

@en

type

label

Mesenchymal stem cells for tre ...... host disease: a phase II study

@ast

Mesenchymal stem cells for tre ...... host disease: a phase II study

@en

prefLabel

Mesenchymal stem cells for tre ...... host disease: a phase II study

@ast

Mesenchymal stem cells for tre ...... host disease: a phase II study

@en

P1433

Q29617267-E80EDC63-20EF-4506-A7A7-0830D7B6DE0E

P1476

Q29617267-2D704AE2-46A9-4FCD-B5C8-4CBB7D704AAB

P2093

Q29617267-1A78DC5E-2893-4985-8F69-0A6DACDFBEB6

Q29617267-1E2A7803-63FF-465D-B2A5-1BA922647AF9

Q29617267-1EAC1DCC-94F9-4C2B-BC67-3A892FD9371C

Q29617267-1F7B7C5D-AEA4-42E6-A67D-B8CDB6F71AE9

Q29617267-239A6AA9-33AC-429B-8BAD-01EC10577E8C

Q29617267-2C061436-FE04-466D-8EF4-1DF6A9A6C74F

Q29617267-2EA92C39-A079-4EC0-AB12-8AE8946D65C0

Q29617267-35FFBE94-4A75-434D-B023-A17AF821A01A

Q29617267-6E6D96A2-F02A-4342-ADA0-BA0126DAF5C9

Q29617267-7A63C29F-BBF1-4334-88B7-7FE969BED7CA

P304

Q29617267-D60283B9-34F8-4658-992D-B3206AAE7D32

P31

Q29617267-3A303E0C-5A34-44F9-8431-BA3937C09A1A

P3181

Q29617267-5877BDF4-051C-4E7F-90ED-126908B983B8

P356

Q29617267-3B6B7275-0C54-4097-BD30-3EBB3A653732

P407

Q29617267-93D77F3E-66F4-4D62-BCF1-295C97392154

P433

Q29617267-86AFC932-E3E3-428D-884A-1CB3BE49238C

P478

Q29617267-A39F35A7-0F19-4E72-B49B-88A392DE74B5

P577

Q29617267-21D63F6E-9AF8-4575-8F49-33B4681D971E

P698

Q29617267-6058FB33-0B83-4FF7-A446-57AB5B44E64B

P3181

P356

S0140-6736(08)60690-X

P1433

P1476

Mesenchymal stem cells for tre ...... host disease: a phase II study

@en

P2093

Bacigalupo A

http://www.w3.org/2001/XMLSchema#string

Ball L

http://www.w3.org/2001/XMLSchema#string

Bernardo ME

http://www.w3.org/2001/XMLSchema#string

Dini G

http://www.w3.org/2001/XMLSchema#string

Egeler RM

http://www.w3.org/2001/XMLSchema#string

Fibbe W

http://www.w3.org/2001/XMLSchema#string

Frassoni F

http://www.w3.org/2001/XMLSchema#string

Lanino E

http://www.w3.org/2001/XMLSchema#string

Le Blanc K

http://www.w3.org/2001/XMLSchema#string

Lewis I

http://www.w3.org/2001/XMLSchema#string

P304

1579-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

297024

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(08)60690-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9624

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18468541

http://www.w3.org/2001/XMLSchema#string